Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
enabled [disable] Abstract
Number of results

Results found: 4

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  MONOAMINE
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
EN
Effect of administration of the standardized extract of Ginkgo biloba leaves (EGb 761) on learning, memory and exploratory behavior was estimated in water maze and hole-board tests. Rats (18-month old) received for three months EGb 761 at doses: 50, 100 and 150 mg/kg b.w. per day. After completion of the behavioral experiment, concentrations of neurotransmitters were estimated in selected brain regions. ANOVA demonstrated significant differences in the content of monoamines and metabolites between the treatment groups compared to the control. The increased level of 5-hydroxytryptamine (5-HT) in the hippocampus and 5-HIAA (5-HT metabolite) in the prefrontal cortex correlated positively with the retention of spatial memory. Positive correlation between platform crossings in SE during the probe trial and neurotransmitter turnover suggest improvement of spatial memory. Long-term administration of Ginkgo biloba extract can improve spatial memory and motivation with significant changes in the content and metabolism of monoamines in several brain regions.
EN
Biogenic monoamines (catecholamines, indoleamines and histamine) are evolutionary old and important modulators of long-lasting changes in the functional state of cells.They are found in many protozoans and in almost all metazoans.Monoamines preserve their evolutionary old functions (first of all being intracellular signals and later hormones and growth factors) even in those animals in which they acquired the function of neurotrasmitter.The older functions of serotonin, an important member of the family of indoleamines, are reviewed here.Described are: presence of serotonin on organisms at various phylogenetic levels; its role in embryonal, foetal and postnatal nervous system.It is concluded that in none of these functions serotonin is the only factor, but it is an ubiquitous and important modulator of a vast array of processes and functions taking part in development and plasticity.
EN
Differences in fear level assessment based on the time of motionless in the illuminated compartment, time spent in light compartment, number of head dipping from dark to the illuminated compartment and number of returns from dark to the illuminated compartment registered in light/dark transitions test and brain monoamines (NA, DA, 5-HT) and their metabolites (MHPG, DOPAC, 5-HIAA) in the hypothalamus, midbrain, amygdala, hippocampus and pons were examined in 3, 12 and 24 months old Wistar rats. The lowest level of fear was registered in 12 months old rats, a slightly higher level in 3 months old rats and the highest in 24 months old rats. Locomotion activity showed a decreasing tendency within age according to a linear dependence in 3, 12 and 24 months old rats. Neurochemical data showed the decreased activity of NA system and increased activity of DA system in most structures already occurred in 12 months old rats. It remained at the same level in aged rats. The correlation analysis between the behavioral markers of fear level and distribution of monoamines in young, mature and aged rats showed diversified data, only some of them being consistent with the 'serotonergic hypothesis' of fear/anxiety. Therefore, we cannot conclude what neurochemical background of fear is.
EN
The effects of R(+)-8-Hydroxy-dipropyl-aminotetralin, (R(+)-8-OHDPAT) and R(+)-5-Fluoro-Hydroxy-dipropyloaminotetralin (R(+)-UH-301) injection into the dorsal raphe nucleus (DRN) on fear behavior in a modified version of the light-dark transitions test and regional brain monoamines (NA, DA, 5-HT) and their metabolites ( MHPG, DOPAC, 5-HIAA) in the hypothalamus (HPT), midbrain central gray matter (MID), amygdala (AMY), hippocampus (HIP) and pons (PO) were examined. An injection of R(+)-8-OHDPAT (300 ng) as well R(+)-UH-301 (300 ng) into the DRN evoked i) an increase in the number of head dipping from dark to the illuminated compartment of chamber; ii) an increase of time spent motionless in the dark compartment; iii) decrease of time of locomotion activity in the illuminated compartment. There was no effect on (1) time out from the illuminated to the dark compartment; (2) time of locomotion activity in the dark compartment; (3) time spent motionless in the illuminated compartment; 4) the number of returns from the dark to the illuminated compartment. HPLC analysis showed reduction of 5-HIAA/5-HT ratio in the HPT, HIP and PO, reduction of 5-HT in the MID, increase of NA content in the HPT and AMY, increase of MHPG/NA ratio in the HIP and PO, and increase of DA content in the HPT, AMY and HIP and increase of DOPAC content in the HIP after R(+)-8-OHDPAT injection into the DRN. But injection of R(+)-UH-301 into the DRN reduced 5-HT in the MID and increased in the AMY, reduced 5-HIAA content in the HIP and increased in the MID, reduced NA content in the HIP and increased in the HPT and decreased MHPG/NA ratio in the PO. These results indicate that both 5-HT1A receptor agonists, R(+)-8-OHDPAT and R(+)-UH-301, acting on the 5HT1A autoreceptors caused the anxiolytic effects, reduced fear behavior on the rat connected with infringement of dynamic balance between the serotonergic and catecholaminergics systems.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.